Improving access to cardiac rehabilitation in Australia: a policy reflection on equitable secondary prevention

Aust Health Rev. 2026 Nov 5;50(5):AH26122. doi: 10.1071/AH26122.ABSTRACTCardiac rehabilitation (CR) is an evidence-based secondary prevention intervention associated with reduced cardiovascular mortality and hospital readmissions and improved quality of life. Despite strong guideline recommendations

S Sampathawaduge Ashail Silva

Progress on the related mechanisms of vascular calcification in autogenous arteriovenous fistula in hemodialysis patients

Ren Fail. 2026 Dec;48(1):2741770. doi: 10.1080/0886022X.2026.2741770. Epub 2026 Oct 12.ABSTRACTAutologous arteriovenous fistula (AVF) is the preferred vascular access for end-stage renal disease patients undergoing maintenance hemodialysis as a replacement therapy. As the duration of dialysis increa

Y Yingdong Guo

The Quo Vadis for COVADIS Diagnostic Criteria

Heart Lung Circ. 2026 Oct 12:S1443-9506(26)00502-0. doi: 10.1016/j.hlc.2026.06.030. Online ahead of print.ABSTRACTThe Coronary Vasomotor Disorders International Study group (COVADIS) developed the diagnostic criteria for vasospastic angina and microvascular angina more than 8 years ago. This article

J John F Beltrame

Interpretation and reporting of coronary computed tomographic angiography (2026 update): An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT)

No abstractJ Cardiovasc Comput Tomogr. 2026 Sep 2:S1934-5925(26)00480-6. doi: 10.1016/j.jcct.2026.08.014. Online ahead of print.NO ABSTRACTPMID:42864251 | DOI:10.1016/j.jcct.2026.08.014

P Prabhakar Shantha Rajiah

Patient preferences for antihypertensive medication dispensing trade-offs in cardiovascular disease prevention: national survey in Australia

No abstractBMJ Open. 2026 Oct 12;16(10):e122691. doi: 10.1136/bmjopen-2026-122691.NO ABSTRACTPMID:42864128 | DOI:10.1136/bmjopen-2026-122691

C Carissa Bonner

OCT-guided versus angiography-guided stent optimisation for post-interventional FFR in patients with complex coronary artery lesions: protocol for a multicentre, open-label, randomised controlled trial (PRECISION-COMPLEX)

No abstractBMJ Open. 2026 Oct 12;16(10):e125834. doi: 10.1136/bmjopen-2026-125834.NO ABSTRACTPMID:42864127 | DOI:10.1136/bmjopen-2026-125834

S Seung Hun Lee

Effects of ONO-6950, a Novel Dual Cysteinyl Leukotriene 1 and 2 Receptor Antagonist, in a Rat Model of Pulmonary Arterial Hypertension

The effects of ONO-6950, a novel dual antagonist of cysteinyl leukotriene 1 (CysLT(1)) and 2 (CysLT(2)) receptors, were examined in a monocrotaline-induced rat model of pulmonary arterial hypertension (PAH). The effects were compared with those of montelukast (selective CysLT(1) receptor antagonist)

A Akihiro Kamiya

Imaging of Vascular Diseases of the Spinal Cord

Neuroimaging Clin N Am. 2026 Nov;36(4):845-861. doi: 10.1016/j.nic.2026.06.013. Epub 2026 Jul 17.ABSTRACTSpinal cord vascular diseases are rare but pose a significant diagnostic challenge and can lead to devastating neurologic injury. Timely diagnosis is challenging given their heterogeneous present

N Neeharika Krothapalli

Particles of Drug-Coated Balloons Captured by Flow Reversal Method

No abstractJACC Cardiovasc Interv. 2026 Oct 12;19(19):2660-2663. doi: 10.1016/j.jcin.2026.07.040.NO ABSTRACTPMID:42863881 | DOI:10.1016/j.jcin.2026.07.040

D Daichi Yoshii

Conduction System Versus Right Ventricular Pacing in Patients Undergoing TAVR: A Multicenter Propensity-Matched Study

JACC Cardiovasc Interv. 2026 Oct 12;19(19):2635-2647. doi: 10.1016/j.jcin.2026.08.008.ABSTRACTBACKGROUND: Pacemaker implantation after transcatheter aortic valve replacement (TAVR) is common and has been associated with adverse clinical outcomes. Cardiac physiological pacing (CPP) may preserve ventr

F Felipe Diez-Delhoyo

Impact of Extent of Coronary Artery Disease in Transcatheter Aortic Valve Replacement: A PRO-TAVI Substudy

JACC Cardiovasc Interv. 2026 Oct 12;19(19):2619-2630. doi: 10.1016/j.jcin.2026.07.034.ABSTRACTBACKGROUND: Coronary artery disease is present in one-half of patients undergoing transcatheter aortic valve replacement (TAVR). The recent randomized controlled PRO-TAVI (Percutaneous Coronary Intervention

G Gijs M Broeze

Intraprocedural Cardiac Arrest in Patients Undergoing Percutaneous Coronary Interventions in the United States: An Analysis of the NCDR CathPCI Registry

JACC Cardiovasc Interv. 2026 Oct 12;19(19):2604-2615. doi: 10.1016/j.jcin.2026.07.035.ABSTRACTBACKGROUND: Cardiac arrest (CA) during percutaneous coronary interventions (PCI) is a catastrophic procedural complication. Contemporary rates of CA during PCI are unknown.OBJECTIVES: This study sought to u

R Ramya C Mosarla

Timing of Nonculprit PCI for STEMI and Multivessel Disease

No abstractJACC Cardiovasc Interv. 2026 Oct 12;19(19):2601-2603. doi: 10.1016/j.jcin.2026.08.009.NO ABSTRACTPMID:42863872 | DOI:10.1016/j.jcin.2026.08.009

M Mohammed A Elbahloul

Immediate Versus Staged Complete Revascularization in Multivessel Disease and STEMI: A Meta-Analysis of Randomized Trials

JACC Cardiovasc Interv. 2026 Oct 12;19(19):2589-2600. doi: 10.1016/j.jcin.2026.07.033.ABSTRACTBACKGROUND: For patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease, complete revascularization is recommended. The timing of nonculprit lesion intervention, either imme

D Daniel O'Callaghan

Frequency and Prognosis of Alternative Definitions of Occlusion Myocardial Infarction Across the Whole Spectrum of Acute Coronary Syndromes

JACC Cardiovasc Interv. 2026 Oct 12;19(19):2571-2585. doi: 10.1016/j.jcin.2026.08.007.ABSTRACTBACKGROUND: Occlusion myocardial infarction (OMI) refers to a myocardial infarction caused by a persistent or transient, complete or near-complete coronary artery occlusion. Multiple definitions have been p

A Andrea Milzi

Occlusion-Focused Triage vs Very-High-Risk NSTEMI Criteria: A DIFOCCULT-3 Substudy

JACC Cardiovasc Interv. 2026 Oct 12;19(19):2555-2566. doi: 10.1016/j.jcin.2026.06.040.ABSTRACTBACKGROUND: The current ST-segment elevation myocardial infarction (STEMI)/NSTEMI framework may not fully identify patients with ACO who present without diagnostic STE. Although immediate invasive managemen

E Emre K Aslanger

Acute Coronary Occlusions in NSTEMI Undergoing Percutaneous Coronary Intervention: Insights From the CathPCI Registry

JACC Cardiovasc Interv. 2026 Oct 12;19(19):2539-2551. doi: 10.1016/j.jcin.2026.07.032.ABSTRACTBACKGROUND: Patients may present with acute coronary occlusions (ACOs) without manifesting electrocardiographic criteria for ST-segment elevation myocardial infarction (STEMI).OBJECTIVES: The aim of this st

R Riyad Yazan Kherallah

Ischemic myocardium-targeted NAD+ nanotherapy mitigates myocardial ischemia/reperfusion injury

J Control Release. 2026 Oct 12:115454. doi: 10.1016/j.jconrel.2026.115454. Online ahead of print.ABSTRACTMyocardial ischemia-reperfusion injury remains a major cause of cardiomyocyte loss and adverse remodeling following acute myocardial infarction, yet effective therapeutic options remain limited.

X Xiahong Xie

Cutaneous Effects and Aesthetic Management of Glucagon-like Peptide-1 Receptor Agonists: A Narrative Review

Clin Dermatol. 2026 Oct 12:S0738-081X(26)00297-X. doi: 10.1016/j.clindermatol.2026.09.041. Online ahead of print.ABSTRACTGlucagon-like peptide-1 receptor agonists (GLP-1RAs) are among the most widely prescribed medications in the United States, with expanding indications beyond type-2 diabetes melli

B Benjamin D Hu

The Prognostic Value of Entropy from T1 Mapping in Pulmonary Arterial Hypertension

J Cardiovasc Magn Reson. 2026 Oct 12:102810. doi: 10.1016/j.jocmr.2026.102810. Online ahead of print.ABSTRACTBACKGROUND: The prognostic value of left ventricular (LV) entropy from T1 mapping in pulmonary arterial hypertension (PAH) remains unexplored.STUDY DESIGN AND METHODS: This prospective study

J Ji Zhao

Genetic susceptibility in Takotsubo syndrome: a candidate gene association analysis in the French TAKOGENE cohort

Eur J Med Genet. 2026 Oct 12:105108. doi: 10.1016/j.ejmg.2026.105108. Online ahead of print.ABSTRACTTakotsubo syndrome (TTS) is a stress-induced left ventricular (LV) cardiomyopathy with an unclear genetic predisposition. We investigated whether single nucleotide polymorphisms (SNPs) previously asso

L Laury Nicolas

Therapeutic strategies in vascular cognitive impairment: Insights from the bilateral common carotid artery stenosis mouse model

Exp Neurol. 2026 Oct 12:116060. doi: 10.1016/j.expneurol.2026.116060. Online ahead of print.ABSTRACTVascular cognitive impairment (VCI) is a major consequence of cerebrovascular disease, but disease-modifying therapies remain limited. Chronic cerebral hypoperfusion is increasingly recognized not sim

Y Yorito Hattori

Ex Vivo Histopathological Validation of Optical Frequency Domain Imaging for Diagnosing Intimal and Medial Calcification in a Single Femoropopliteal Lesion

J Vasc Interv Radiol. 2026 Oct 12:109139. doi: 10.1016/j.jvir.2026.109139. Online ahead of print.ABSTRACTOptical frequency domain imaging (OFDI) is available to guide atherectomy for severely calcified femoropopliteal lesions in patients with lower extremity artery disease, although its diagnostic a

H Haruya Yamane

Impact of Simple Vascular Quality Initiative Frailty Score on Outcomes of Venous Leg Ulcer Healing and Recurrence

Ann Vasc Surg. 2026 Oct 12:S0890-5096(26)00710-7. doi: 10.1016/j.avsg.2026.09.053. Online ahead of print.ABSTRACTOBJECTIVE: Up to 1% of patients with chronic venous disease will present with a primary venous Leg Ulcer (VLU). This study aimed to analyze the impact of frailty as measured by the Simple

J Joseph P Hart